TrialJournal of the neurological sciences2015

GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding.

Jay S Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.